Budget Battles
-
What Harris and Trump Said on Taxes and Healthcare at the Debate
Last night’s debate between Vice President Kamala Harris and former President Donald Trump likely won’t be remembered for fiscal policy points as much as, say, discussion about abortion, immigration...
-
Biden Cap on Drug Costs Will Save Millions an Average $1,500 Next Year: Analysis
The new cap on out-of-pocket prescription drug costs enacted as part of the 2022 Inflation Reduction Act will save more than 3 million Medicare beneficiaries an average of $1,500 next year, according...
-
Harris Targets Middle-Class Affordability in New Economic Agenda
By Michael Rainey and Yuval RosenbergVice President Kamala Harris on Friday outlined the economic policies she aims to pursue in the first 100 days of her administration, including proposals to subsidize homebuyers, reward families with...
-
Biden, Harris Celebrate Medicare Drug Price Cuts That Will Save Billions
By Michael RaineyAppearing together for the first time since she replaced him atop the Democratic ticket, President Joe Biden and Vice President Kamala Harris on Thursday celebrated a milestone in the new program...
-
Childhood Vaccinations Have Delivered Huge Benefits Over 3 Decades: CDC
Routine childhood vaccinations have benefitted the public immensely over the past three decades, in both economic and health terms, according to a new analysis by the Centers for Disease Control and...
-
National Uninsured Rate Rises in 2024
By Michael RaineyAfter hitting a record low of 7.2% last year, the percentage of the U.S. population without health insurance rose to 8.2% in the first quarter of 2024, according to new data from the Centers for...
-
Powerful Middlemen Are Jacking Up Drug Prices: FTC
By Michael RaineyThe middlemen who buy and sell prescription drugs throughout the U.S. healthcare system are inflating prices for consumers, according to an interim report released Tuesday by the Federal Trade...
-
Insurers Bilk Medicare for $50 Billion to Treat Fictitious Illnesses
By Michael RaineyPrivate insurance firms running Medicare Advantage programs have been overcharging the federal government billions of dollars by making patients look sicker than they really are, according to a...
-
Biden Administration to Reduce Prices on Dozens of Prescription Drugs in Medicare
By Michael RaineyThe Biden administration announced Wednesday that it will reduce the prices of 64 prescription drugs for Medicare enrollees as part of its effort to combat soaring pharmaceutical costs. The price...
-
CBO Raises Its 2024 Deficit Forecast 27% to Nearly $2 Trillion
By Michael RaineyThe federal budget deficit will reach an estimated $1.9 trillion in fiscal year 2024, according to an updated outlook released by the Congressional Budget Office Tuesday. The new projection...
-
Americans’ Top Financial Worry: Healthcare
By Michael RaineyHealthcare issues claim the top spots in the list of things U.S. voters are “very” or “somewhat worried” about being able to afford, according to the latest tracking poll from the healthcare...
-
New Record for Obamacare Signups
By Michael RaineyA record 20 million people have signed up for health care through the marketplaces created by the Affordable Care Act, the Centers for Medicare and Medicaid Services announced Wednesday. This marks...
-
As Drug Prices Rise, $35 Cap on Insulin Takes Effect
By Michael RaineyPharmaceutical companies rang in the New Year as they usually do: raising prices on hundreds of medications. According to research cited by Reuters , companies like Pfizer, Sanofi and Takeda will...
-
More Than Half of Children Losing Medicaid Coverage Live in Just 5 States
By Michael RaineyAs individual states continue to disenroll millions of people from Medicaid and the Children’s Health Insurance Program (CHIP) now that pandemic-era suspension of participation guidelines has come to...
-
Biden Admin Threatens to Seize Publicly Funded Drug Patents
By Michael RaineyThe Biden administration took steps Thursday that could clear the way for the federal government to seize the patents of high-priced pharmaceuticals that were developed using public funds. The move...